Use of a wearable device to compare subjective and objective fatigue in lung cancer patients and cancer-free controls
European Journal of Oncology Nursing · 2024
DOI: 10.1016/j.ejon.2024.102587 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Oncology Nursing, 2024. Verfasst von Ting-Ling Chou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Fatigue, Lung Neoplasms, Wearable Electronic Devices, Heart Rate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Science and Technology Council.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: The study evaluates the use of heart rate variability (HRV), a measure of autonomic nervous system (ANS) modulation via wearable smart bands, to objectively assess cancer-related fatigue (CRF) levels. It aims to enhance understanding of fatigue by distinguishing between LF/HF ratios and LF/HF disorder ratios through HRV and photoplethysmography (PPG), identifying them as potential biomarkers. METHODS: Seventy-one lung cancer patients and 75 non-cancer controls wore smart bands for one week. Fatigue was assessed using Brief Fatigue Inventory, alongside sleep quality and daily interference. HRV parameters were analyzed to compare groups. RESULTS: Cancer patients showed higher fatigue and interference levels than controls (64.8% vs. 54.7%). Those with mild fatigue had elevated LF/HF disorder ratios during sleep (40% vs. 20%, P = 0.01), similar to those with moderate to severe fatigue (50% vs. 20%, P = 0.01), indicating more significant autonomic dysregulation. Notably, mild fatigue patients had higher mean LF/HF ratios than controls (1.9 ± 1.34 vs. 1.2 ± 0.6, P = 0.01), underscoring the potential of disorder ratios in signaling fatigue severity. CONCLUSIONS: Utilizing wearable smart bands for HRV-based analysis is feasible for objectively assess CRF levels in cancer patients, especially during sleep. By distinguishing between LF/HF ratios and LF/HF disorder ratios, our findings suggest that wearable technology and detailed HRV analysis offer promising avenues for real-time fatigue monitoring. This approach has the potential to significantly improve cancer care by providing new methods for managing and intervening in CRF, particularly with a focus on autonomic dysregulation as a crucial factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
- Department of Computer Science and Information Engineering, National Chin-Yi University of Technology, Taichung, Taiwan.
- Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Division of Thoracic Medicine, Department of Internal Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.
- Division of Gastroenterology & Hepatology, Department of Internal Medicine, Erlin Christian Hospital, Changhua, Taiwan.
- School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan; Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan; Research Center in Nursing Clinical Application, Wan Fang Hospital, Taipei Me…
Förderung
- National Science and Technology Council
Zitieren
APA
Chou, T. L., Shih, C. H., Chou, P. C., Lai, J. H., & Huang, T. W. (2024). Use of a wearable device to compare subjective and objective fatigue in lung cancer patients and cancer-free controls. European Journal of Oncology Nursing. https://doi.org/10.1016/j.ejon.2024.102587
Vancouver
Chou TL, Shih CH, Chou PC, Lai JH, Huang TW. Use of a wearable device to compare subjective and objective fatigue in lung cancer patients and cancer-free controls. European Journal of Oncology Nursing. 2024. doi:10.1016/j.ejon.2024.102587
BibTeX
@article{Chou2024,
author = {Chou, Ting-Ling and Shih, Chi-Huang and Chou, Pai-Chien and Lai, Jun-Hung and Huang, Tsai-Wei},
title = {Use of a wearable device to compare subjective and objective fatigue in lung cancer patients and cancer-free controls},
journal = {European Journal of Oncology Nursing},
year = {2024},
doi = {10.1016/j.ejon.2024.102587}
}
EUVIMED